实验性生殖技术在卵巢储备功能降低的不孕女性中的潜在作用。
Potential roles of experimental reproductive technologies in infertile women with diminished ovarian reserve.
机构信息
Division of Reproductive Endocrinology and Infertility, Fertility and Advanced Reproductive Medicine Assisted Reproductive Technologies Program, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
出版信息
J Assist Reprod Genet. 2021 Oct;38(10):2507-2517. doi: 10.1007/s10815-021-02246-6. Epub 2021 Jun 7.
Abstract
In assisted reproductive technology treatment, diminished ovarian reserve (DOR) is a condition of utmost clinical and scientific relevance because of its negative influence on patient outcomes. The current methods of infertility treatment may be unsuitable for many women with DOR, which support the need for development of additional approaches to achieve fertility restoration. Various techniques have been tried to improve the quality and increase the quantity of oocytes in DOR patients, including mitochondrial transfer, activation of primordial follicles, in vitro culture of follicles, and regeneration of oocytes from various stem cells. Herein, we review the science behind these experimental reproductive technologies and their potential use to date in clinical studies for infertility treatment in women with DOR.
摘要
在辅助生殖技术治疗中，卵巢储备功能降低（DOR）是一种极具临床和科学意义的疾病，因为它对患者结局有负面影响。目前的不孕治疗方法可能不适合许多 DOR 患者，这支持需要开发额外的方法来实现生育力恢复。已经尝试了各种技术来改善 DOR 患者卵母细胞的质量和数量，包括线粒体转移、原始卵泡的激活、卵泡的体外培养以及各种干细胞来源的卵母细胞的再生。在此，我们回顾了这些实验性生殖技术背后的科学原理及其迄今为止在 DOR 女性不孕症临床研究中的潜在用途。
相似文献
1
Potential roles of experimental reproductive technologies in infertile women with diminished ovarian reserve.实验性生殖技术在卵巢储备功能降低的不孕女性中的潜在作用。
J Assist Reprod Genet. 2021 Oct;38(10):2507-2517. doi: 10.1007/s10815-021-02246-6. Epub 2021 Jun 7.
2
Severity of Diminished Ovarian Reserve and Chance of Success with Assisted Reproductive Technology.卵巢储备功能减退的严重程度与辅助生殖技术的成功几率
J Reprod Med. 2017 Mar-Apr;62(3-4):153-60.
3
Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.对卵巢储备功能下降的不孕妇女进行新鲜卵巢皮质组织活检、分割和自体移植。
Hum Reprod. 2019 Oct 2;34(10):1924-1936. doi: 10.1093/humrep/dez152.
4
Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.美国辅助生殖技术人群中卵巢储备功能减退：来自辅助生殖技术协会诊所结局报告系统的181,536个周期的诊断趋势
Fertil Steril. 2015 Sep;104(3):612-19.e3. doi: 10.1016/j.fertnstert.2015.05.017. Epub 2015 Jun 11.
5
Prospects of Germline Nuclear Transfer in Women With Diminished Ovarian Reserve.卵母细胞储备功能降低女性中行种系核转移的前景。
Front Endocrinol (Lausanne). 2021 Feb 22;12:635370. doi: 10.3389/fendo.2021.635370. eCollection 2021.
6
Treatment Progress in Diminished Ovarian Reserve: Western and Chinese Medicine.卵巢储备功能下降的中西医治疗进展
Chin J Integr Med. 2023 Apr;29(4):361-367. doi: 10.1007/s11655-021-3353-2. Epub 2022 Jan 11.
7
Association of ABO blood groups with ovarian reserve, and outcomes after assisted reproductive technology: systematic review and meta-analyses.ABO 血型与卵巢储备功能及辅助生殖技术结局的关系：系统评价和荟萃分析。
Reprod Biol Endocrinol. 2021 Feb 6;19(1):20. doi: 10.1186/s12958-020-00685-x.
8
Surgical approaches of drug-free in vitro activation and laparoscopic ovarian incision to treat patients with ovarian infertility.无药物辅助的体外激活和腹腔镜卵巢切开术治疗卵巢性不孕患者的手术方法。
Fertil Steril. 2020 Dec;114(6):1355-1357. doi: 10.1016/j.fertnstert.2020.07.029. Epub 2020 Sep 6.
9
Health needs, treatment decisions and experience of traditional complementary and integrative medicine use by women with diminished ovarian reserve: A cross-sectional survey.卵巢储备功能降低女性的健康需求、治疗决策和传统补充与整合医学使用体验：一项横断面调查。
Aust N Z J Obstet Gynaecol. 2024 Aug;64(4):390-398. doi: 10.1111/ajo.13805. Epub 2024 Mar 21.
10
Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates.诊断和治疗 40 岁以下女性辅助生殖技术周期中的卵巢储备功能减退：保险授权的作用。
Fertil Steril. 2013 Feb;99(2):382-8. doi: 10.1016/j.fertnstert.2012.09.026. Epub 2012 Oct 23.
引用本文的文献
1
Advances in Traditional Chinese Medicine for Managing Diminished Ovarian Reserve: Mechanisms and Clinical Insights.中医治疗卵巢储备功能下降的研究进展：作用机制与临床见解
Drug Des Devel Ther. 2025 Jul 1;19:5597-5614. doi: 10.2147/DDDT.S505689. eCollection 2025.
2
IVF/ICSI treatment for patients with diminished ovarian reserve with or without Kuntai capsule pretreatment: a retrospective cohort study stratified by a controlled ovarian stimulation regimen.对有或无坤泰胶囊预处理的卵巢储备功能减退患者进行体外受精/卵胞浆内单精子注射治疗：一项按控制性卵巢刺激方案分层的回顾性队列研究
Front Endocrinol (Lausanne). 2025 Jun 5;16:1598998. doi: 10.3389/fendo.2025.1598998. eCollection 2025.
3
Plasminogen activator inhibitor 1 is a novel predictor in human serum/follicular fluid for diminished ovarian reserve.纤溶酶原激活物抑制剂1是人类血清/卵泡液中卵巢储备功能下降的一种新型预测指标。
BMC Womens Health. 2025 Apr 29;25(1):210. doi: 10.1186/s12905-025-03710-6.
4
Study on the mechanism of Jiawei Shoutai Pill in the treatment of diminished ovarian reserve based on network pharmacology.基于网络药理学探讨加味寿胎丸治疗卵巢储备功能下降的作用机制
Medicine (Baltimore). 2025 Feb 28;104(9):e41729. doi: 10.1097/MD.0000000000041729.
5
Associations of the levels of adipokines and cytokines in individual follicles with in vitro fertilization outcomes in women with different ovarian reserves.不同卵巢储备功能女性个体卵泡中脂肪因子和细胞因子水平与体外受精结局的相关性
J Ovarian Res. 2025 Jan 22;18(1):11. doi: 10.1186/s13048-025-01594-6.
6
miR-361-5p regulates SLC25A24 to maintain mitochondrial function and alleviate granulosa cell dysfunction in diminished ovarian reserve.miR-361-5p通过调控SLC25A24来维持线粒体功能并减轻卵巢储备功能减退中的颗粒细胞功能障碍。
J Assist Reprod Genet. 2025 Mar;42(3):923-936. doi: 10.1007/s10815-024-03349-6. Epub 2025 Jan 14.
7
Analysis of single-cell RNA sequencing in human oocytes with diminished ovarian reserve uncovers mitochondrial dysregulation and translation deficiency.分析卵巢储备功能降低的人类卵母细胞的单细胞 RNA 测序，揭示了线粒体功能紊乱和翻译缺陷。
Reprod Biol Endocrinol. 2024 Nov 15;22(1):146. doi: 10.1186/s12958-024-01321-8.
8
Positive Effect of 25-Hydroxyvitamin D (25(OH)D) Levels in Follicular Fluid on Embryonic Developmental Potential in Diminished Ovarian Reserve (DOR) Patients Undergoing Microstimulation.卵泡液中25-羟基维生素D（25(OH)D）水平对接受微刺激的卵巢储备功能减退（DOR）患者胚胎发育潜能的积极影响
Cureus. 2024 Aug 8;16(8):e66436. doi: 10.7759/cureus.66436. eCollection 2024 Aug.
9
Benefit from luteal phase progestin primed ovarian stimulation with clomiphene citrate supplementation in young women with diminished ovarian reserve: a retrospective study.在卵巢储备功能减退的年轻妇女中，使用枸橼酸氯米酚补充黄体期孕激素预刺激：一项回顾性研究。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 May 16;53(3):297-305. doi: 10.3724/zdxbyxb-2023-0533.
10
Predictive Factors for the Formation of Viable Embryos in Subfertile Patients with Diminished Ovarian Reserve: A Clinical Prediction Study.预测卵巢储备功能减退的不孕患者形成可存活胚胎的因素：一项临床预测研究。
Reprod Sci. 2024 Jun;31(6):1747-1756. doi: 10.1007/s43032-024-01469-z. Epub 2024 Feb 26.
本文引用的文献
1
A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet-Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency.一项评估自体富血小板血浆卵巢内输注对卵巢储备功能低下或卵巢功能不全患者疗效的系统评价。
Cureus. 2020 Dec 12;12(12):e12037. doi: 10.7759/cureus.12037.
2
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human.自体脂肪来源间充质基质细胞卵巢内移植治疗特发性卵巢早衰患者的安全性、可行性和有效性评估：非随机临床试验，I 期，首次人体试验。
J Ovarian Res. 2021 Jan 6;14(1):5. doi: 10.1186/s13048-020-00743-3.
3
Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review.近年来，干细胞治疗卵巢早衰及其治疗潜力的研究进展：综述。
J Ovarian Res. 2020 Jun 23;13(1):74. doi: 10.1186/s13048-020-00671-2.
4
Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency.自身富含血小板血浆卵巢内注射对原发性卵巢功能不全患者卵巢储备功能及 IVF 结局参数的影响。
Aging (Albany NY). 2020 Jun 5;12(11):10211-10222. doi: 10.18632/aging.103403.
5
What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?ART/IVF 中卵巢刺激不良反应者的最佳方案是什么？
Front Endocrinol (Lausanne). 2020 Apr 17;11:192. doi: 10.3389/fendo.2020.00192. eCollection 2020.
6
Single-cell analysis of human ovarian cortex identifies distinct cell populations but no oogonial stem cells.单细胞分析人类卵巢皮质可鉴定出不同的细胞群体，但不存在卵原干细胞。
Nat Commun. 2020 Mar 2;11(1):1147. doi: 10.1038/s41467-020-14936-3.
7
Mini Review; Differentiation of Human Pluripotent Stem Cells into Oocytes.综述：人类多能干细胞向卵母细胞的分化。
Curr Stem Cell Res Ther. 2020;15(4):301-307. doi: 10.2174/1574888X15666200116100121.
8
Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve.在卵巢储备功能下降的卵巢反应不良患者中，为不孕治疗进行无药物的体外卵泡激活。
Reprod Biomed Online. 2020 Feb;40(2):245-253. doi: 10.1016/j.rbmo.2019.09.007. Epub 2019 Sep 19.
9
Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.对卵巢储备功能下降的不孕妇女进行新鲜卵巢皮质组织活检、分割和自体移植。
Hum Reprod. 2019 Oct 2;34(10):1924-1936. doi: 10.1093/humrep/dez152.
10
FERTILITY PRESERVATION: Progress and prospects for developing human immature oocytes in vitro.生育力保存：体外培养人类未成熟卵母细胞的进展与前景。
Reproduction. 2019 Nov;158(5):F45-F54. doi: 10.1530/REP-19-0077.
Zotero 插件